By Attending This Course, You WillUnderstand product maturity and be prepared for what happens at patent expiry.Know which drivers of differentiation can be used in a seemingly undifferentiated world.Learn where, when and how to compete in a generic world using pricing and contracting strategies, authorised and own generic strategies, Rx to OTC switching strategies, etc.Learn how to select the best tactics for your brand(s).Be able to take portfolio management decisions at late stage.Know how to build winning organisations in late stage LCM.Gain insights from real world LCM case studies and benefit from Neal’s insightful recommendations based on his unique background as a senior consultant in working on LCM solutions for many pharma companies.Why You Should AttendThe Content: This is the only public course entirely focused on LCM in the later stages of a pharmaceutical's lifecycle. The content is based on the expertise Dr. Neal Hansen built through his numerous consulting assignments for pharma companies in the area of LCM, which culminated in a book he co-authored with Dr Tony Ellery (ex-Novartis): Pharmaceutical Lifecycle Management - Making the Most of Each and Every Brand published by Wiley and Sons in mid-2012. Neal enriches his course with insightful recommendations he has drawn from working on pharma LCM solutions, in a format that fosters interaction and learning.The Expert: Not only is Dr. Neal Hansen highly knowledgeable about pharma LCM, he is also a talented speaker – very lively and passionate about this subject. He has worked globally with senior executives in the pharma industry across therapeutic areas and is very knowledgeable about realities in the national markets.The Late Stage Pharma Lifecycle Management course is the only available public training course delivered by Dr. Neal Hansen on the topic of lifecycle management.